お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は放出制御型ドラッグデリバリー市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは放出制御型ドラッグデリバリーの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の放出制御型ドラッグデリバリー市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは放出制御型ドラッグデリバリーのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に放出制御型ドラッグデリバリー市場を分類しています。本研究に含まれる主な企業は：Depomed、Coating Place、Corium、Johnson and Johnson、Alkermes、Pfizer、Orbis Biosciences、Capsugel、Merck、Aradigm

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Wurster Technique
    Coacervation
    Micro Encapsulation
    Implants
    Transdermal
    Targeted Delivery
    Others

用途別の市場セグメント：
    Metered Dose Inhalers
    Injectables
    Transdermal and Ocular Patches
    Infusion Pumps
    Oral Controlled-Drug Delivery Systems
    Drug Eluting Stents

本レポートの詳細内容
世界の放出制御型ドラッグデリバリー市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、放出制御型ドラッグデリバリータイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の放出制御型ドラッグデリバリー収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の放出制御型ドラッグデリバリー市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、放出制御型ドラッグデリバリー市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

放出制御型ドラッグデリバリーのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：放出制御型ドラッグデリバリーのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：放出制御型ドラッグデリバリーの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章放出制御型ドラッグデリバリー企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：放出制御型ドラッグデリバリーの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：放出制御型ドラッグデリバリーの主要企業の概要を提供し、製品の説明と仕様、放出制御型ドラッグデリバリーの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time.

Market Analysis and Insights: Global Controlled Release Drug Delivery Market
The global Controlled Release Drug Delivery market is projected to grow from US$ 47000 million in 2024 to US$ 74320 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Controlled Release Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Controlled Release Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Controlled Release Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Controlled Release Drug Delivery revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Controlled Release Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Controlled Release Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Depomed, Coating Place, Corium, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel and Merck, etc.

Market Segmentation
By Company
    Depomed
    Coating Place
    Corium
    Johnson and Johnson
    Alkermes
    Pfizer
    Orbis Biosciences
    Capsugel
    Merck
    Aradigm

Segment by Type
    Wurster Technique
    Coacervation
    Micro Encapsulation
    Implants
    Transdermal
    Targeted Delivery
    Others

Segment by Application
    Metered Dose Inhalers
    Injectables
    Transdermal and Ocular Patches
    Infusion Pumps
    Oral Controlled-Drug Delivery Systems
    Drug Eluting Stents

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Controlled Release Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Controlled Release Drug Delivery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Controlled Release Drug Delivery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Controlled Release Drug Delivery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Wurster Technique
    Table 3. Key Players of Coacervation
    Table 4. Key Players of Micro Encapsulation
    Table 5. Key Players of Implants
    Table 6. Key Players of Transdermal
    Table 7. Key Players of Targeted Delivery
    Table 8. Key Players of Others
    Table 9. Global Controlled Release Drug Delivery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 10. Global Controlled Release Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Controlled Release Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Controlled Release Drug Delivery Market Share by Region (2019-2024)
    Table 13. Global Controlled Release Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Controlled Release Drug Delivery Market Share by Region (2025-2030)
    Table 15. Controlled Release Drug Delivery Market Trends
    Table 16. Controlled Release Drug Delivery Market Drivers
    Table 17. Controlled Release Drug Delivery Market Challenges
    Table 18. Controlled Release Drug Delivery Market Restraints
    Table 19. Global Controlled Release Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Controlled Release Drug Delivery Revenue Share by Players (2019-2024)
    Table 21. Global Top Controlled Release Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Controlled Release Drug Delivery as of 2023)
    Table 22. Global Controlled Release Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
    Table 23. Global 5 Largest Players Market Share by Controlled Release Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Global Key Players of Controlled Release Drug Delivery, Headquarters and Area Served
    Table 25. Global Key Players of Controlled Release Drug Delivery, Product and Application
    Table 26. Global Key Players of Controlled Release Drug Delivery, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Controlled Release Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Controlled Release Drug Delivery Revenue Market Share by Type (2019-2024)
    Table 30. Global Controlled Release Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Controlled Release Drug Delivery Revenue Market Share by Type (2025-2030)
    Table 32. Global Controlled Release Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Controlled Release Drug Delivery Revenue Share by Application (2019-2024)
    Table 34. Global Controlled Release Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Controlled Release Drug Delivery Revenue Share by Application (2025-2030)
    Table 36. North America Controlled Release Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 37. North America Controlled Release Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 38. North America Controlled Release Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 39. North America Controlled Release Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 40. North America Controlled Release Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. North America Controlled Release Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
    Table 42. North America Controlled Release Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Europe Controlled Release Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 44. Europe Controlled Release Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 45. Europe Controlled Release Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 46. Europe Controlled Release Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 47. Europe Controlled Release Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Europe Controlled Release Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Europe Controlled Release Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
    Table 50. China Controlled Release Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 51. China Controlled Release Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 52. China Controlled Release Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 53. China Controlled Release Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Controlled Release Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 55. Asia Controlled Release Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 56. Asia Controlled Release Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 57. Asia Controlled Release Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 58. Asia Controlled Release Drug Delivery Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 59. Asia Controlled Release Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
    Table 60. Asia Controlled Release Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Controlled Release Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 66. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
    Table 68. Depomed Company Details
    Table 69. Depomed Business Overview
    Table 70. Depomed Controlled Release Drug Delivery Product
    Table 71. Depomed Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 72. Depomed Recent Developments
    Table 73. Coating Place Company Details
    Table 74. Coating Place Business Overview
    Table 75. Coating Place Controlled Release Drug Delivery Product
    Table 76. Coating Place Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 77. Coating Place Recent Developments
    Table 78. Corium Company Details
    Table 79. Corium Business Overview
    Table 80. Corium Controlled Release Drug Delivery Product
    Table 81. Corium Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 82. Corium Recent Developments
    Table 83. Johnson and Johnson Company Details
    Table 84. Johnson and Johnson Business Overview
    Table 85. Johnson and Johnson Controlled Release Drug Delivery Product
    Table 86. Johnson and Johnson Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 87. Johnson and Johnson Recent Developments
    Table 88. Alkermes Company Details
    Table 89. Alkermes Business Overview
    Table 90. Alkermes Controlled Release Drug Delivery Product
    Table 91. Alkermes Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 92. Alkermes Recent Developments
    Table 93. Pfizer Company Details
    Table 94. Pfizer Business Overview
    Table 95. Pfizer Controlled Release Drug Delivery Product
    Table 96. Pfizer Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 97. Pfizer Recent Developments
    Table 98. Orbis Biosciences Company Details
    Table 99. Orbis Biosciences Business Overview
    Table 100. Orbis Biosciences Controlled Release Drug Delivery Product
    Table 101. Orbis Biosciences Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 102. Orbis Biosciences Recent Developments
    Table 103. Capsugel Company Details
    Table 104. Capsugel Business Overview
    Table 105. Capsugel Controlled Release Drug Delivery Product
    Table 106. Capsugel Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 107. Capsugel Recent Developments
    Table 108. Merck Company Details
    Table 109. Merck Business Overview
    Table 110. Merck Controlled Release Drug Delivery Product
    Table 111. Merck Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 112. Merck Recent Developments
    Table 113. Aradigm Company Details
    Table 114. Aradigm Business Overview
    Table 115. Aradigm Controlled Release Drug Delivery Product
    Table 116. Aradigm Revenue in Controlled Release Drug Delivery Business (2019-2024) & (US$ Million)
    Table 117. Aradigm Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Controlled Release Drug Delivery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Controlled Release Drug Delivery Market Share by Type: 2023 VS 2030
    Figure 3. Wurster Technique Features
    Figure 4. Coacervation Features
    Figure 5. Micro Encapsulation Features
    Figure 6. Implants Features
    Figure 7. Transdermal Features
    Figure 8. Targeted Delivery Features
    Figure 9. Others Features
    Figure 10. Global Controlled Release Drug Delivery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Controlled Release Drug Delivery Market Share by Application: 2023 VS 2030
    Figure 12. Metered Dose Inhalers Case Studies
    Figure 13. Injectables Case Studies
    Figure 14. Transdermal and Ocular Patches Case Studies
    Figure 15. Infusion Pumps Case Studies
    Figure 16. Oral Controlled-Drug Delivery Systems Case Studies
    Figure 17. Drug Eluting Stents Case Studies
    Figure 18. Controlled Release Drug Delivery Report Years Considered
    Figure 19. Global Controlled Release Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 20. Global Controlled Release Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 21. Global Controlled Release Drug Delivery Market Share by Region: 2023 VS 2030
    Figure 22. Global Controlled Release Drug Delivery Market Share by Players in 2023
    Figure 23. Global Top Controlled Release Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Controlled Release Drug Delivery as of 2023)
    Figure 24. The Top 10 and 5 Players Market Share by Controlled Release Drug Delivery Revenue in 2023
    Figure 25. North America Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. North America Controlled Release Drug Delivery Market Share by Type (2019-2030)
    Figure 27. North America Controlled Release Drug Delivery Market Share by Application (2019-2030)
    Figure 28. North America Controlled Release Drug Delivery Market Share by Country (2019-2030)
    Figure 29. United States Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Canada Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Europe Controlled Release Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 32. Europe Controlled Release Drug Delivery Market Share by Type (2019-2030)
    Figure 33. Europe Controlled Release Drug Delivery Market Share by Application (2019-2030)
    Figure 34. Europe Controlled Release Drug Delivery Market Share by Country (2019-2030)
    Figure 35. Germany Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. France Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. U.K. Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Italy Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Russia Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Nordic Countries Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Controlled Release Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. China Controlled Release Drug Delivery Market Share by Type (2019-2030)
    Figure 43. China Controlled Release Drug Delivery Market Share by Application (2019-2030)
    Figure 44. Asia Controlled Release Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 45. Asia Controlled Release Drug Delivery Market Share by Type (2019-2030)
    Figure 46. Asia Controlled Release Drug Delivery Market Share by Application (2019-2030)
    Figure 47. Asia Controlled Release Drug Delivery Market Share by Region (2019-2030)
    Figure 48. Japan Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. South Korea Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. China Taiwan Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Southeast Asia Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. India Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Australia Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 55. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Share by Type (2019-2030)
    Figure 56. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Share by Application (2019-2030)
    Figure 57. Middle East, Africa, and Latin America Controlled Release Drug Delivery Market Share by Country (2019-2030)
    Figure 58. Brazil Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Mexico Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Turkey Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Saudi Arabia Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Israel Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. GCC Countries Controlled Release Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 64. Depomed Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 65. Coating Place Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 66. Corium Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 67. Johnson and Johnson Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 68. Alkermes Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 69. Pfizer Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 70. Orbis Biosciences Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 71. Capsugel Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 72. Merck Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 73. Aradigm Revenue Growth Rate in Controlled Release Drug Delivery Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed